CareMax Overview
Valuation check: CMAX's ROE is 529.82%, above the Healthcare sector average of 29.33%.
Get informed when a big investor buys or sells
+ Follow529.82%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CareMax (CMAX) currently reports a ROE of 529.82%. That is above the Healthcare sector average of 29.33%. Use the charts on this page to explore CareMax's ROE history and peer comparisons.
CareMax's ROE of 529.82% is higher than the Healthcare sector average of 29.33%. That is roughly 1706.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CareMax's current 529.82% should be judged against Healthcare norms (sector average: 29.33%) and against CMAX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 529.82%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for CareMax, and consider following CMAX for alerts when major investors trade the stock.
CareMax is classified in the Healthcare sector. On ROE, it currently shows 529.82% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMAX with unrelated industries.
